Publications by authors named "Dorothee Gramatzki"

25Publications

Antidepressant drug use in glioblastoma patients: an epidemiological view.

Neurooncol Pract 2020 Oct 25;7(5):514-521. Epub 2020 Apr 25.

Department of Neurology & Brain Tumor Center, Clinical Neuroscience Center, University Hospital and University of Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npaa022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516105PMC
October 2020

End-of-life care for glioma patients; the caregivers' perspective.

J Neurooncol 2020 May 30;147(3):663-669. Epub 2020 Mar 30.

Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-020-03471-2DOI Listing
May 2020

Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma.

J Cancer Res Clin Oncol 2020 Mar 21;146(3):659-670. Epub 2019 Nov 21.

Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-03086-9DOI Listing
March 2020

Complementary and alternative medicine use in glioma patients in France.

J Neurooncol 2019 Dec 21;145(3):487-499. Epub 2019 Oct 21.

Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03315-8DOI Listing
December 2019

Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.

J Neurochem 2020 05 8;153(4):510-524. Epub 2020 Jan 8.

Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jnc.14899DOI Listing
May 2020

Management of Elderly Patients with Glioblastoma.

Curr Neurol Neurosci Rep 2017 04;17(4):35

Department of Neurology and Brain Tumor Center, University Hospital Zurich and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-017-0740-3DOI Listing
April 2017

Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.

Neurology 2017 Apr 15;88(15):1422-1430. Epub 2017 Mar 15.

From the Department of Neurology and Brain Tumor Center (D.G., M.W.), University Hospital Zurich and University of Zurich, Switzerland; Department of Neuroradiology (P.K., M.B.), University Hospital of Heidelberg; Institute for Medical Informatics, Statistics and Epidemiology (B.H., M.L.), University of Leipzig; Departments of Neuropathology (J.F., G.R.) and Neurosurgery (M.S.), Heinrich-Heine University Düsseldorf; Division of Neurooncology (U.H.), Department of Neurology, University Medical Center Bonn; Department of Neurosurgery (G.S.), University of Dresden; Department of Neurosurgery (J.-C.T.), Ludwig Maximilians University Munich; Department of Neurosurgery (M.W.), University Medical Center Hamburg-Eppendorf, Hamburg; Department of Neurology (U.S.), Knappschaftskrankenhaus Bochum-Langendreer, Ruhr-University Bochum; Clinical Cooperation Unit Neurooncology (W.W.), German Cancer Consortium, German Cancer Research Center, and Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg; Department of Neuropathology (T.P.), DGNN Brain Tumor Reference Center, University of Bonn Medical School; and German Cancer Consortium (G.R.), German Cancer Research Center Heidelberg, Partner Site Essen/Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003809DOI Listing
April 2017

Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.

Cancer 2016 12 13;122(23):3740-3741. Epub 2016 Sep 13.

Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30340DOI Listing
December 2016

Interleukin-33 in human gliomas: Expression and prognostic significance.

Oncol Lett 2016 Jul 25;12(1):445-452. Epub 2016 May 25.

Institute of Pathology Liestal, Cantonal Hospital Baselland, 4410 Liestal, Switzerland; Department of Pathology, Institute of Surgical Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4626DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906635PMC
July 2016

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

Expert Opin Pharmacother 2016 Jun 21;17(9):1259-70. Epub 2016 Apr 21.

a Department of Neurology and Brain Tumor Center , University Hospital and University of Zurich , Zurich , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2016.1176146DOI Listing
June 2016

Transforming growth factor-β pathway activity in glioblastoma.

Oncotarget 2015 Mar;6(8):5963-77

Laboratory for Molecular Neuro-Oncology, Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467414PMC
http://dx.doi.org/10.18632/oncotarget.3467DOI Listing
March 2015

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.

Neurology 2013 Oct 25;81(17):1515-22. Epub 2013 Sep 25.

From the Departments of Neuro-oncology (W.W., M.P., A.S., B.W., M. Weiler) and Neuropathology (A.v.D.), University of Heidelberg; German Cancer Consortium (DKTK) (W.W., B.W., M. Weiler), Clinical Cooperation Unit Neuro-oncology and Clinical Cooperation Unit Neuropathology (A.v.D.), German Cancer Research Center, Heidelberg; Department of Medical Biometry (C.M.), University of Tübingen; Institute for Medical Informatics, Statistics and Epidemiology (B.H., M.L.), University Leipzig; Departments of Neurosurgery (M.C.S.) and Neuropathology (G.R.), Heinrich-Heine-University and DKTK (G.R.), Düsseldorf; Department of Neurology (S.K.), University of Essen Medical School; Department of Neurosurgery (R.K.), Saarland University, Homburg, Germany; Department of Neurology (G.T., D.G., M. Weller), University Hospital Zurich, Switzerland; Department of Neurosurgery (M. Westphal), University Clinic Hamburg Eppendorf, Hamburg; Department of Neurosurgery (G.S.) and DKTK (G.S.), Technical University Dresden; and Department of Neurosurgery (M.S.), University of Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e3182a95680DOI Listing
October 2013

Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.

Int J Cancer 2009 Aug;125(3):530-40

Department of General Neurology, Laboratory of Molecular Neuro-Oncology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24443DOI Listing
August 2009